Combination therapies of HDAC inhibitors and PD-1 inhibitors
RP Bissonnette, A Rolland, M Gillings - US Patent 10,385,130, 2019 - Google Patents
Provided herein are combinations that include an HDACi and a PD-1 inhibitor that are useful
for treating cancer, including reducing and/or preventing cancer metastasis. The …
for treating cancer, including reducing and/or preventing cancer metastasis. The …
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
RP Bissonnette, A Rolland, M Gillings - US Patent 10,385,131, 2019 - Google Patents
US10385131B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors - Google
Patents US10385131B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors …
Patents US10385131B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors …
Combination therapies of HDAC inhibitors and PD-1 inhibitors
RP Bissonnette, A Rolland, M Gillings - US Patent 10,287,353, 2019 - Google Patents
2020-10-07 Assigned to HUYA BIOSCIENCES INTERNATIONAL, LLC reassignment HUYA
BIOSCIENCES INTERNATIONAL, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
BIOSCIENCES INTERNATIONAL, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereof
SN Quayle, SS Jones, T Hideshima… - US Patent …, 2022 - Google Patents
The present disclosure relates to a pharmaceutical combi nation comprising (a) a histone
deacetylase 6 inhibitor and (b) a programmed death ligand 1 (PD-L1) inhibitor, includ ing …
deacetylase 6 inhibitor and (b) a programmed death ligand 1 (PD-L1) inhibitor, includ ing …
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
RP Bissonnette, A Rolland, M Gillings - US Patent 11,535,670, 2022 - Google Patents
US11535670B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors - Google
Patents US11535670B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors …
Patents US11535670B2 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors …
Combination therapies of HDAC inhibitors and PD-1 inhibitors
RP Bissonnette, A Rolland, M Gillings - US Patent 12,122,833, 2024 - Google Patents
Provided herein are combinations that include an HDACi and a PD-1 inhibitor that are useful
for treating cancer, including reducing and/or preventing cancer metastasis. The …
for treating cancer, including reducing and/or preventing cancer metastasis. The …